Upper Airway's Pressure Drop Analyses After Mandibular Advancement and Maxillary Expansion
Launched by UNIVERSITY OF ALBERTA · Dec 5, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain orthodontic treatments, specifically mandibular advancement (moving the lower jaw forward) and maxillary expansion (widening the upper jaw), can improve breathing in children with specific dental issues. Researchers want to see if these treatments can increase the space in the upper airway, which might help children breathe more easily. They aim to find out if changes in the shape or size of the airway can lead to better airflow and less effort when breathing. This is important because breathing difficulties in children can lead to problems with behavior and learning.
To participate in this study, children aged 8 to 14 years old who have certain dental conditions may be eligible. Specifically, the trial is looking for boys aged 9-14 and girls aged 8-12 who have a specific type of bite issue known as skeletal class II division 1 malocclusion, along with a narrower upper jaw. However, children with certain health problems or those who have had previous orthodontic treatments may not qualify. Participants can expect to undergo assessments to measure their airway volume and airflow both before and after treatment, helping researchers understand how these orthodontic techniques can make breathing easier for kids.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • children between the ages 8-14 years old (8-12 years old girls and 9-14 years old boys), presenting skeletal class II division 1 malocclusion with maxillary constriction
- Exclusion Criteria:
- • syndromic patients, previous ortho history, non-compliance, severe oral health issues (cavities, poor oral hygiene)
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Silvia G Capenakas, MSc
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials